Solaris Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Solaris Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,200	Closed	-$135K	–	67
2017 Q4	$135K	Hold	2,200	–	–	0.08%	115
2017 Q3	$140K	Buy	+2,200	New	+$128K	0.08%	109
2017 Q2	–	Sell	-2,200	Closed	-$120K	–	298
2017 Q1	$120K	Hold	2,200	–	–	0.08%	116
2016 Q4	$129K	Hold	2,200	–	–	0.08%	111
2016 Q3	$119K	Sell	2,200 -44	-2%	-$2.83K	0.08%	115
2016 Q2	$165K	Buy	2,244 +75	+3%	+$5.3K	0.12%	83
2016 Q1	$139K	Hold	2,169	–	–	0.1%	81
2015 Q4	$149K	Hold	2,169	–	–	0.1%	77
2015 Q3	$128K	Buy	2,169 +44	+2%	+$2.79K	0.1%	82
2015 Q2	$141K	Hold	2,125	–	–	0.09%	104
2015 Q1	$137K	Hold	2,125	–	–	0.08%	112
2014 Q4	$125K	Hold	2,125	–	–	0.08%	112
2014 Q3	$109K	Hold	2,125	–	–	0.07%	119
2014 Q2	$103K	Sell	2,125 -75	-3%	-$3.7K	0.07%	114
2014 Q1	$114K	Sell	2,200 -2,000	-48%	-$106K	0.08%	105
2013 Q4	$223K	Sell	4,200 -12,175	-74%	-$620K	0.15%	99
2013 Q3	$758K	Buy	16,375 +375	+2%	+$16.5K	0.55%	58
2013 Q2	$715K	Buy	+16,000	New	+$695K	0.57%	57

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Solaris Asset Management's BMY Position: Q1 2018 in Review

Solaris Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 2,200 shares — an estimated $135K sold.

Solaris Asset Management first reported a position in BMY in Q2 2013 and held it in 18 quarters. The position peaked at $758K in Q3 2013. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

Solaris Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
Solaris Asset Management sold 2,200 Bristol-Myers Squibb shares in Q1 2018, an estimated $135K.
Solaris Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 18 quarters.
Solaris Asset Management's Bristol-Myers Squibb position peaked at $758K in Q3 2013.
1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Solaris Asset Management's 13F filing for Q1 2018, filed 16 Apr 2018.